5 January 2018

Diurnal Group plc

('Diurnal' or the 'Company')

Director Dealings

Diurnal Group plc (AIM: DNL), the specialty pharmaceutical company targeting patient needs in chronic endocrine (hormonal) diseases, announces that Non-Executive Director, John Goddard, has acquired 10,791 recently vested shares at £0.05 per share.

As published in the Company's AIM Admission Document, published on 21 December 2015, and in connection with his recruitment, John Goddard was awarded 32,374 ordinary shares of £0.05 each for which Mr Goddard will pay the nominal value for each share. The award of shares vest in thirds 18, 24 and 36 months from 24 December 2015, being the date of admission to AIM. There are no other performance criteria.

John Goddard's interest in the Company is now as follows:

Name

Position

Total number of conditional shares now held

Total number of ordinary shares now held

John Goddard

Non-Executive Director

10,792

37,774

For further information, please visitwww.diurnal.co.ukor contact:

Diurnal Group plc

+44 (0)20 3727 1000

Martin Whitaker, Chief Executive Officer

Richard Bungay, Chief Financial Officer

Numis Securities Ltd (Nominated Adviser)

+44 (0)20 7260 1000

Nominated Adviser: Michael Meade, Paul Gillam, Freddie Barnfield

Corporate Broking: James Black

Panmure Gordon (UK) Limited (Joint Broker)

+44 (0) 20 7886 2500

Corporate Finance: Freddy Crossley

Corporate Broking: Tom Salvesen

FTI Consulting

+44 (0)20 3727 1000

Simon Conway

Victoria Foster Mitchell

Notes to Editors

About Diurnal Group plc

Founded in 2004, Diurnal is a UK-based specialty pharma company developing high quality products for the global market for the life-long treatment of chronic endocrine conditions, including Congenital Adrenal Hyperplasia and Adrenal Insufficiency. Its expertise and innovative research activities focus on circadian-based endocrinology to yield novel product candidates in the rare and chronic endocrine disease arena.

For further information about Diurnal, please visitwww.diurnal.co.uk

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

John Goddard

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Diurnal Group plc

b)

LEI

213800I2HNUNZN1LDH29

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of 5p each

Identification code

GB00BDB6Q760

b)

Nature of the transaction

Purchase of shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£539.55

10,791

d)

Aggregated information

- Aggregated volume

10,791

- Price

£539.55

e)

Date of the transaction

5 January 2018

f)

Place of the transaction

London Stock Exchange, AIM

Diurnal Group plc published this content on 05 January 2018 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 05 January 2018 13:29:08 UTC.

Original documenthttp://otp.investis.com/clients/uk/diurnal_limited/rns/regulatory-story.aspx?cid=1282&newsid=963712

Public permalinkhttp://www.publicnow.com/view/A9A1D7C28CBEBCFB655BE59F023C7913C4A16A0C